Omsättningen i Q4 uppgick till 6,0 MSEK (12,7) och EBIT till -2,0 MSEK (5,5), påverkat av valutamotv...
Systemair levererar stabil marginal och starkt kassaflöde men missar vinstförväntningarna, vilket ty...
* Focus on sport/wellness, dental and smaller centres * Adj.
Redeye gives a short initial comment on the new promising data from the ongoing CARMA-study with ELC...
IDL Diagnostics has announced that CEO Anders Hultman will step down, with the board initiating a se...
Nettoomsättningen uppgick till 0,6 MSEK (1,2) och övriga rörelseintäkter till 1,4 MSEK (2,6), vilket...
Systemair’s Q3 report offered some surprises, mainly related to sales in the various regions where o...
Solwers' Q4 sales were weak, 11% below our expectation, and EBITA of EUR 1.
Redeye reinforces its positive view of Lime following the CMD.
Alzecure förbereder sedan en länge tid en fas 2a-studie med bolagets innovativa projekt ACD856, en s...
Administer delivered a clear profitability beat in Q4 despite continued top-line headwinds.
Solwers reported its results for Q4 with sales of EUR 20.
Yesterday evening, Hansa Biopharma announced a PDUFA date of 19 December, indicating a standard rath...
Cicor reported H2 2025 sales of CHF 235.8m (2% vs. NDA and Bloomberg consensus), up 34.
Redeye has updated its estimates following Heliospectra’s Q4 2025 report.
Redeye is impressed by Safeture’s new partnership deal that was announced yesterday.
Although we see that Leaddesk’s ARR was negatively impacted by regulatory changes in some European c...
Seafire today announced the acquisition of Splendor Plant, the Nordic leader in wholesales plant nur...
Administer's Q4 results were mixed, with net sales declining slightly more than we had estimated, wh...
